Immune Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: Observations at a Cancer Center

Immune checkpoint inhibitors (ICIs) have rapidly changed the landscape of oncologic care and are now often used in the front line setting for many types of cancers. These agents attempt to harness the immune system to target cancer cells (ICIs) by releasing inhibition of T cell response against tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeun, Rebecca, Best, Conor, Iyer, Priyanka, Lavis, Victor Ralph, Varghese, Jeena Mary, Oliva, Isabella Glitza, Dadu, Ramona, Thosani, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090364/
http://dx.doi.org/10.1210/jendso/bvab048.847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090364/
http://dx.doi.org/10.1210/jendso/bvab048.847

Ejemplares similares